109054 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against enzymes
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
#2102Protein engineered systems for delivery of molecules
#2103Anticancer combinations
#2104Methods and Compositions for Increasing the Efficacy of Doxorubicin Treatment in the Treatmentof Prostate Related Disorders using miR-106b-25 Cluster
#2105Fidgetin-like 2 as a target to enhance wound healing
#2106Organic small hairpin RNAs
#2107Compositions and methods for increasing erythropoietin (EPO) production
#2108Sphingolipid-polyalkylamine-oligonucleotide compounds
#2109Clusterin Antisense Therapy for Treatment of Cancer
#2110ANTISENSE DESIGN
#2111ANTISENSE DESIGN
#2112CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS
#2113Modulation of axon degeneration
#2114Methods for suppressing adipocyte differentiation
#2115COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING MUSCULAR DYSTROPHY
#2116Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#2117Multi-tailed lipids and uses thereof
#2118BGL6 beta-glucosidase and nucleic acids encoding the same
#2119Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#2120Compositions and methods for controlled delivery of inhibitory ribonucleic acids
#2121METHODS AND MATERIALS FOR TREATING CANCER
#2122Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor
#2123RIG-I ligands and methods for producing them
#2124Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
#2125Compositions and methods for treating alzheimer's disease and other tauopathies
#2126TMPRSS6 iRNA compositions and methods of use thereof
#2127Compositions and methods for inhibiting expression of TMPRSS6 gene
#2128LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#2129METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USE
#2130Age-related macular degeneration treatment
#2131Compositions and methods for the delivery of nucleic acids
#2132Dosage compensating transgenes and cells
#2133Methods and compositions for modulating cancer stem cells
#2134COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS
#2135Oligonucleotide conjugates
#2136Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity
#2137Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#2138METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT
#2139Agents for improved delivery of nucleic acids to eukaryotic cells
#2140Interfering RNA molecules
#2141RNA amidates and thioamidates for RNAi
#2142Methods and compositions for prognosis, diagnosis, and treatment of ADAM8-expressing cancer
#2143SHIP INHIBITION TO COMBAT OBESITY
#2144METHOD OF SCREENING FOR CHAPERONIN MODULATOR
#2145Autoimmune disease treatments
#2146Methods and pharmaceutical compositions for the treatment of erythropoietic protoporphyria
#2147Methods and compositions for reducing immunosupression by tumor cells
#2148QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGET
#2149PROTEIN INVOLVED IN DNA REPLICATION, AND MODULATION OF ITS ACTIVITY
#2150Molecules of the card-related protein family and uses thereof
#2151In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells
#2152Inhibition of MAP4K4 through RNAi
#2153SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA
#2154Compositions and methods for inhibiting expression of the ALAS1 gene
#2155Amine-containing lipidoids and uses thereof
#2156MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
#2157Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#2158METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#2159Nucleic acid aptamers
#2160Use of PKC-iota inhibitors for the treatment of breast cancer
#2161CANCER EXAMINATION METHOD AND EXAMINATION KIT
#2162DOUBLE STRANDED RNA COMPOUNDS TO RHOA AND USE THEREOF
#2163Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
#2164QSOX1 as an anti-neoplastic drug target
#2165Use of hydrogen sulfide synthesis inhibitors for cancer therapy
#2166Composition and method for inner ear sensory hair cell regeneration and replacement
#2167Modulators of itch ubiquitinase activity
#2168NOVEL TREATMENT OF METABOLIC DISEASES
#2169Synthetic lethality in cancer
#2170METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS
#2171Therapeutic compositions
#2172Pharmaceutical composition for treating liver diseases
#2173Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#2174Modulation of dystrophia myotonica-protein kinase (DMPK) expression
#2175Brush-poly (glycoamidoamine)-lipids and uses thereof
#2176Method for treating breast cancer by targeting breast cancer stem cell
#2177Composition comprising inhibitor against PAPSS2 gene or protein encoded by gene for inducing senescence in tumor cells and method for inducing senescence in tumor cells using the same
#2178Compositions and methods for reducing neointima formation
#2179RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#2180Double stranded RNA constructs for aphid control
#2181Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor
#2182Bruton's tyrosine kinase as anti-cancer drug target
#2183Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#2184METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1
#2185P-coumaroyl-CoA:monolignol transferase
#2186Materials and Methods Useful For Affecting Tumor Cell Growth, Migration and Invasion
#2187Targeting chromatin modifiers for the treatment of medical conditions
#2188Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection
#2189Mutations in DSTYK cause dominant urinary tract malformations
#2190Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
#2191siRNA-mediated gene silencing
#2192COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC AND IMAGING AGENTS TO THE SINUSES AND MIDDLE EAR
#2193Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#2194Combination therapy for MDS
#2195Biomarkers associated with BRM inhibition
#2196Methods and compositions related to T-cell activity
#2197Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT
#2198Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
#2199Methods for increasing efficacy of lipid formulated siRNA
#2200Medicament for liver regeneration and for treatment of liver failure
#2201COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENE
#2202PCSK9 iRNA compositions and methods of use thereof
#2203Lipid-Coated Albumin Nanoparticle Compositions and Methods of Making and Method of Using the Same
#2204Compositions and methods for reducing skin pigmentation
#2205Gene silencing of sugar-dependent 1 in
#2206Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#2207Method of altering vascular permeability and uses thereof
#2208Methods and Compositions for the Prevention and Treatment of Parasitic Disease
#2209Methods of treating cancer
#2210Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
#2211Method and compositions for the genetic control of insect pests in cotton plants by chitin synthase gene silencing
#2212Methods to identify and treat subjects having corticosteroid-resistant asthma
#2213Modified oligonucleotides for telomerase inhibition
#2214Lipid formulations for delivery of therapeutic agents to solid tumors
#2215Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
#2216Furin-knockdown bi-functional RNA
#2217USE OF VEGFR1 AS A BIOMARKER
#2218Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family
#2219LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
#2220Methods of treating cholangiocarcinoma
#2221Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
#2222METHODS OF MODULATING DLK STABILITY
#2223METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES
#2224Transcription factor which regulates flavonoid, phenylpropanoid, tyrosine, and tryptophan pathways
#2225MELK regulation for the treatment of breast cancer
#2226Polyvalent RNA-nanoparticle compositions
#2227DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
#2228Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#2229USP30 INHIBITORS AND METHODS OF USE
#2230siRNA FOR INHIBITION OF USP15 EXPRESSION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#2231RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
#2232Compounds and methods for modulating gene expression
#2233Targeted sensitization of non-del(5q) malignant cells
#2234Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
#2235FURTHER USE OF PROTEIN KINASE N BETA
#2236dsRNA For Treating Viral Infection
#2237Phosphoribosyl pyrophosphate synthetase 2 (PRPS2) as a therapeutic target in cancer treatment
#2238COMPOSITIONS AND METHODS TARGETING SIGNALING BY THE G PROTEIN BETA-GAMMA SUBUNIT FOR THE TREATMENT OF ASTHMA
#2239Oligonucleotide compositions and methods of making the same
#2240MUCOSAL HEALING PROMOTER
#2241Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same
#2242Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#2243LDH inhibitors as treatment for fibrosis and fibrotic-related disorders
#2244Methods of treating an overweight subject
#2245Pharmaceutical Compositions and Diagnostic Methods for Inflammatory Skin Diseases, Disorders or Conditions
#2246Methods of treating ischemia-reperfusion injury with siRNAs
#2247Peptides useful for modulating histone demethylase function
#2248Apoptosis-inducing agent
#2249Method and pharmaceutical composition for inhibiting PI3K/AKT/mTOR signaling pathway
#2250METHOD OF PRODUCING BIOFUEL USING MICROALGAE CULTURES
#2251Modified oligonucleotides for telomerase inhibition
#2252Modified oligonucleotides for telomerase inhibition
#2253Synthetic Nucleic Acids for Polymerization Reactions
#2254Antisense modulation of PTP1B expression
#2255Compositions and Methods for Modulation of ATXN3 Expression
#2256Compositions and methods for selective delivery of oligonucleotide molecules to cell types
#2257Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2258Methods for diagnosing and treating prostate cancer
#2259Multiple targeted RNAI for the treatment of cancers
#2260In vivo gene silencing by chemically modified and stable siRNA
#2261EGVII Endoglucanase and Nucleic Acids Encoding the Same
#2262THERAPEUTIC AND DIAGNOSTIC TARGET GENE IN ACUTE MYELOID LEUKEMIA
#2263Inhibition of histone methyltransferase for cardiac reprogramming
#2264METHODS OF TREATMENT OF SKIN ULCERS
#2265Animal model for type 2 diabetes and obesity
#2266Method of treatment of SETDB1 expressing cancer
#2267METHODS AND COMPOSITIONS TO PRODUCE ss-RNAi ACTIVITY WITH ENHANCED POTENCY
#2268Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#2269PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#2270Therapeutics with conformationally restricted monomers
#2271BGL7 Beta-Glucosidase and Nucleic Acids Encoding the Same
#2272Polymeric nanoparticles
#2273Carboxylated polyamine derivatives as transfection reagents
#2274RIG-I ligands and methods for producing them
#2275Delivery of dsRNA to arthropods
#2276Polypeptides having peroxygenase activity
#2277Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof
#2278ADAM-15 ANTIBODIES AND IMMUNOGENIC PEPTIDES
#2279TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY
#2280Compositions and methods for regulating arterial tone
#2281Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#2282Agents for the prevention and/or treatment of central nervous system damage
#2283Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#2284Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2285Methods of treating hemoglobinopathies
#2286GALL WASP CONTROL AGENTS
#2287UGT8 mini-promoters
#2288Polypeptides having peroxygenase activity
#2289Method of treating cancer
#2290Nanocarriers and their processing for diagnostics and therapeutics
#2291METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#2292Targets in multiple myeloma and other disorders
#2293Identification and use of target genes for control of plant parasitic nematodes
#2294Detecting and Treating Liver Damage
#2295Use of ADCY3 for diagnosis and treatment of gastric cancer
#2296Muteins of the pyrroline-5-carboxylate reductase 1
#2297Compositions And Methods For Inhibiting Expression Of IKK-B Gene
#2298Pain treatment using ERK2 inhibitors
#2299MSF REPROGRAMS MYOFIBROBLASTS TOWARD LACTATE PRODUCTION AND FUEL ANAERBOIC TUMOR GROWTH
#2300METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING MATRIX METALLOPROTEINASES 1 BY INTERFERENCE RIBONUCLEIC ACID
#2301Polypeptides having peroxygenase activity
#2302Methods and compositions for treating cancer
#2303Nucleic acid molecules that target the vacuolar atpase C subunit and confer resistance to coleopteran pests
#2304Euchromatic region targeting methods for modulating gene expression
#2305Oligonucleotide—containing pharmacological compositions and their use
#2306TELOMERASE INHIBITORS FOR USE IN THERAPY
#2307Treatment of pain by inhibition of USP5 de-ubiquitinase
#2308Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#2309WOUND TREATMENT
#2310Polypeptides having peroxygenase activity
#2311PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF
#2312Compositions and methods for detecting and treating colorectal cancer
#2313Predicting and treating diabetic complications
#2314PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF
#2315Inhibition of oxidative stress in atrial fibrillation
#2316INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER
#2317Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2318Di-aliphatic substituted pegylated lipids
#2319MUTAGENESIS METHODS
#2320Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
#2321Sense oligonucleotide capable of controlling the expression of INOS and composition comprising the same
#2322LEPIDOPTERAN INSECT N-ACETYLGLUCOSAMINIDASE GENES AND THEIR USE IN GLYCOENGINEERING
#2323Lipid compositions
#2324WOUND HEALING
#2325Methods and compositions for in vivo induction of pancreatic beta cell formation
#2326Method to treat or prevent herpesvirus infections
#2327Compositions Comprising RAC Mutants, and Methods of Use Thereof
#2328Antisense Oligonucleotides Against Neutral Sphingomyelinase and Neutral Sphingomyelinase Inhibitor GW4869 for Degenerative Neurological Disorders
#2329EML4-ALK fusion gene
#2330Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#2331USE OF COX-3 BINDING MOLECULES FOR MODULATING AUTOPHAGY
#2332TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#2333Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#2334Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation
#2335Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same
#2336TARGET GENES FOR CONTROL OF PLANT PARASITIC NEMATODES AND USE OF SAME
#2337Nucleic acid molecules that confer resistance to coleopteran pests
#2338Cationic lipid
#2339Amine-containing transfection reagents and methods for making and using same
#2340Antisense modulation of superoxide dismutase 1, soluble expression
#2341TREATMENT OF SIALIDASE 4 (NEU4) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NEU4
#2342Oligomeric compounds and methods
#2343Methods for treating hypercholesterolemia
#2344OLIGONUCLEOTIDE INHIBITORS OF DNA METHYLTRANSFERASES AND THEIR USE IN TREATING DISEASES
#2345Gene vector
#2346TIKI inhibitors
#2347Lipid formulations
#2348Stable non-aggregating nucleic acid lipid particle formulations
#2349Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
#2350Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#2351Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#2352COMPOSITIONS AND METHODS FOR MODULATING PTEN EXPRESSION
#2353Compositions and methods for modulating ATP2A2 expression
#2354Treatments of oxidative stress conditions
#2355Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#2356Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#2357Method for enhanced fermentation through the destruction of mitochondrial DNA in yeast
#2358MIRNAS AS THERAPEUTIC TARGETS IN CANCER
#2359Isoform of Bruton's Tyrosine Kinase (BTK) Protein
#2360USP37 inactivation as a treatment for PLZF/RARA-associated acute promyelocytic leukemia
#2361Methods and compositions for inhibiting the growth and/or proliferation of MYC-driven tumor cells
#2362Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway
#2363Composition comprising miRNA for enhancing radiation sensitivity
#2364Compound and method for treating myotonic dystrophy
#2365Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
#2366Compositions for controlling mites in bees
#2367Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#2368PYRUVATE DEHYROGENASE KINASES AS THERAEUTIC TARGETS FOR CANCER AND ISCHEMIC DISEASES
#2369Compositions and methods for inducing myoblast differentiation and myotube formation
#2370MicroRNAs and Uses Thereof
#2371Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand RNA virus infections
#2372Lipid nanoparticle compositions and methods of making and methods of using the same
#2373Compositions and Methods for Inhibiting Expression of RRM2 Genes
#2374Inhibition of DNA2 in fanconi anemia
#2375Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage
#2376Compositions and methods for inhibiting expression of the ALAS1 gene
#2377Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#2378Interfering RNA molecules
#2379Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#2380Novel Activation and Transfer Cascade for Ubiquitin
#2381LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#2382Compositions and methods for the treatment of VprBP-related cancers
#2383NEURONAL DIFFERENTIATION PROMOTER
#2384OLIGONUCLEOTIDE COMPOSITIONS WITH ENHANCED EFFICIENCY
#2385Rational design of microRNA-siRNA chimeras for multi-functional target suppression
#2386Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#2387Methods of Treating Hepatitis C Virus Infection
#2388METHOD FOR TREATING CELL PROLIFERATIVE DISORDER BY INHIBITING C1GALT1 EXPRESSION
#2389MODULATION OF LINE-1 REVERSE TRANSCRIPTASE
#2390Compositions And Methods For Inhibiting Expression Of CD45 Gene
#2391COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF siRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#2392NUCLEIC ACIDS ENCODING INACTIVE VARIANTS OF HUMAN TELOMERASE
#2393RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
#2394PHARMACEUTICAL COMPOSITION FOR VIRAL TREATMENT, AND METHOD FOR SCREENING ANTIVIRAL AGENT
#2395Reduction of formation of amidated amino acids in cell lines for protein expression
#2396Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#2397Method for treatment of diabetes by a small molecule inhibitor for GRK5
#2398Agents and methods for treating and preventing seborrheic keratosis
#2399NON-CATALYTIC DOMAIN TARGETS IN MATRIX METALLOPROTEASE PROTEINS FOR CANCER THERAPIES
#2400Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene